BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 2, 2015
View Archived Issues
Pfizer reflects on milestones of third quarter 2015
Read More
Charleston Laboratories and Daiichi Sankyo report data from phase III study of CL-108
Read More
Emory University divulges AEP inhibitors
Read More
Immunovaccine's RSV candidate is well tolerated in phase I trial
Read More
Ultragenyx and Arcturus collaborate to develop mRNA therapeutics for rare diseases
Read More
7-Methylxanthine reduces myopia progression in children
Read More
Nano-diamino-tetraiodothyroacetic acid named orphan drug in the U.S.
Read More
OncoSec Medical starts biomarker study of ImmunoPulse IL-12 in triple-negative breast cancer
Read More
Preclinical studies of Shigellosis-typhoid bivalent vaccine
Read More
Sumitomo Dainippon offers overview of second quarter of fiscal 2015
Read More
MedImmune discloses anti-IL-21 MAbs
Read More
Zhejiang University and Shanghai Institute of Materia Medica patent proteasome inhibitors
Read More
Bayer Schering Pharma reports CDK9/cyclin-T1 inhibitors
Read More
Sanofi introduces GPR119 agonists
Read More
Isis Pharmaceuticals divulges SOD-1 modified ASOs
Read More
Ferring's Rekovelle MAA filing accepted by EMA
Read More
Mochida files NDA for MD-0901 for ulcerative colitis in Japan
Read More
Memory and learning deficits restored using neurotrophic factor mimetic in AD aged mice
Read More
PLX-3397 receives FDA breakthrough therapy designation for tenosynovial giant cell tumor
Read More
Porcupine inhibitor blocks growth of Wnt-upregulated tumors in mice
Read More
Researchers create refined animal model of experimental autoimmune encephalomyelitis
Read More
Canbex Therapeutics initiates phase II trial of VSN-16R for spasticity in MS
Read More
Cellceutix updates status of brilacidin program
Read More
Novel assay for the diagnosis of MKD demonstrates 100% accuracy
Read More
Chugai describes phase I candidate PTH1 receptor agonist PCO-371
Read More
Merck KGaA and Selvita extend cancer drug discovery collaboration
Read More
AbbVie applies for approval of new indication for Humira in Japan
Read More